Nordion to sell Belgian business to Best Medical
This article was originally published in Clinica
Executive Summary
Nordion has agreed to sell its Belgian operations to Best Medical Belgium, part of the Best Medical International group. The deal does not include Nordion's microsphere-based anticancer treatment TheraSphere, which showed promising results in a trial in liver cancer last year (www.clinica.co.uk, 8 October 2010). Best Medical will acquire Nordion's Glucotrace fludeoxyglucose (FDG) imaging agent, its industrial radiography business, Agiris, and its radiochemical business, which produces generic cyclotron and reactor isotopes used in nuclear imaging. It will also gain all of Nordion's Belgian employees, except those involved in developing TheraSphere, and its Belgian facilities, based in Fleurus. Ottawa, Canada-based Nordion, previously called MDS Nordion, decided to exit or restructure its Belgian business last year after the segment made a loss. Financial details of the deal were not disclosed.